RCEL vs ECOR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
RCEL Captures Institutional Edge (3โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Avita Medical, Inc. Common Stock (RCEL) driven by superior Valuation, Momentum & Technical, Options & Structure while ECOR counters with relative strength in Growth & Margin. Fundamentally, RCEL trades at 10.3x Forward P/E with -33.9% operating margin (+53.1% YoY revenue) versus ECOR at N/M Forward P/E and -33.1% operating margin (+11.5% YoY). In options structure, RCEL sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro) against ECOR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | RCEL Revenue | ECOR Revenue | RCEL Op. Margin | ECOR Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $0M | $0M | -1489.9% | -5494.1% | RCEL |
| FY2019 | $10M | $0M | -466.4% | -1928.2% | RCEL |
| FY2020 | $10M | $0M | -299.2% | -707.9% | RCEL |
| FY2021 | $30M | $10M | -90.8% | -367.7% | RCEL |
| FY2022 | $30M | $10M | -79.9% | -266.2% | RCEL |
| FY2023 | $50M | $20M | -85.1% | -120.2% | RCEL |
| FY2024 | $60M | $30M | -88.1% | -48.3% | ECOR |
| FY2025 | $70M | $30M | -59.4% | -41.1% | ECOR |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | RCEL | ECOR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $506.7M | $44.7M | Larger Scale | RCEL |
| Trailing P/E Ratio Valuation | 10.3x | N/M | Lower Multiple | RCEL |
| Forward P/E Ratio Valuation | 10.3x | N/M | Lower Multiple | RCEL |
| Revenue Growth (YoY) Growth | +53.1% | +11.5% | Higher Growth | RCEL |
| Operating Margin (TTM) Profitability | -33.9% | -33.1% | Higher Margin | ECOR |
| Net Profit Margin Profitability | -42.6% | -33.5% | Higher Margin | ECOR |
| Return on Equity (ROE) Capital Efficiency | -1746.3% | -478.7% | Higher ROE | ECOR |
| 52-Week Range Position Momentum | 82% ($3โ$18) | 6% ($4โ$13) | Stronger Trend | RCEL |
| Beta / 30D Volatility Risk Regime | 1.54ฮฒ ยท 65% Vol | 1.55ฮฒ ยท 155% Vol | Lower Realized Risk | RCEL |
| Unified Institutional Score Composite Signal | 45.6 / 100 (HOLD) | 44.5 / 100 (HOLD) | Higher Composite | RCEL |